Atlas Trials

Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS

Clinical trial NCT04643691 · TERMINATED

Trial details

NCT number
NCT04643691
Sponsor
Assistance Publique Hopitaux De Marseille
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19ARDS
Start date
2020-09-11
Primary completion
2021-12-07
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.